Canadian drug shortage brief: 2026-11-11 to 2026-11-18 97 products with a new shortage report, 127 reports updated, 45 marked resolved. 1615 products have an open report. 27 are Tier 3. New, with no other same-ingredient product free of a report (19) - OMNIPAQUE 240 518MG Solution (GE HEALTHCARE CANADA INC, DIN 02172739): no other marketed product; est. end 2027-02-10 - DIACOMIT 500MG Capsule (BIOCODEX SAS, DIN 02398966): no other marketed product; est. end 2026-12-22 - XARELTO 103.4MG Granules for suspension (BAYER INC, DIN 02510170): no other marketed product; est. end 2027-01-18 - TEVA-5 ASA 400MG Tablet (enteric-coated) (TEVA CANADA LIMITED, DIN 02171929): no other marketed product; no end date given - MYLAN-INDAPAMIDE 1.25MG Tablet (MYLAN PHARMACEUTICALS ULC, DIN 02240067): the 1 other product is also short; est. end 2026-12-01 - MEGESTROL 160MG Tablet (AA PHARMA INC, DIN 02195925): no other marketed product; est. end 2026-12-04 - APO-INDAPAMIDE 1.25 MG TABLETS 1.25MG Tablet (APOTEX INC, DIN 02245246): the 1 other product is also short; no end date given - TOUJEO SOLOSTAR 300UNIT Solution (SANOFI-AVENTIS CANADA INC, DIN 02441829): the 1 other product is also short; est. end 2027-05-31 - TEVA-CHLORPROMAZINE 100MG Tablet (TEVA CANADA LIMITED, DIN 00232831): no other marketed product; est. end 2026-11-30 - TEVA-HALOPERIDOL 10MG Tablet (TEVA CANADA LIMITED, DIN 00713449): no other marketed product; est. end 2027-01-10 - TEVA-NAPROXEN EC 500MG Tablet (enteric-coated) (TEVA CANADA LIMITED, DIN 02243314): the 1 other product is also short; est. end 2026-12-30 - TRURAPI 100UNIT Solution (SANOFI-AVENTIS CANADA INC, DIN 02529254): no other marketed product; est. end 2027-05-31 - AA-LEVOCARB CR 50MG / 200MG Tablet (extended-release) (AA PHARMA INC, DIN 02245211): no other marketed product; est. end 2027-01-08 - MEGESTROL 40MG Tablet (AA PHARMA INC, DIN 02195917): no other marketed product; est. end 2026-12-04 - APO-NAPROXEN EC 500MG Tablet (enteric-coated) (APOTEX INC, DIN 02246701): the 1 other product is also short; est. end 2027-01-22 - APIDRA 100UNIT Solution (SANOFI-AVENTIS CANADA INC, DIN 02279479): all 2 others also short; est. end 2027-05-31 - GLYCOPYRROLATE INJECTION 0.2MG Liquid (OMEGA LABORATORIES LIMITED, DIN 02382857): no other marketed product; est. end 2027-01-13 - GRANISETRON HYDROCHLORIDE INJECTION 1MG Liquid (OMEGA LABORATORIES LIMITED, DIN 02322765): no other marketed product; est. end 2026-11-23 - ENGERIX-B 20MCG Suspension (GLAXOSMITHKLINE INC, DIN 02487039): no other marketed product; est. end 2026-12-11 New, on drugs with only one or two makers (9) - DEPO-MEDROL 40MG Suspension (PFIZER CANADA ULC, DIN 01934333): 1 other product with no open report (check presentation); est. end 2026-12-14 - CLIMARA 75 75MCG Patch (BAYER INC, DIN 02247500): 1 other product with no open report (check presentation); est. end 2027-01-15 - ZELDOX 20MG Capsule (BGP PHARMA ULC, DIN 02298597): 1 other product with no open report; est. end 2027-01-19 - APO-INDAPAMIDE 2.5MG TABLETS 2.5MG Tablet (APOTEX INC, DIN 02223678): 1 other product with no open report; no end date given - APO-BRIVARACETAM 75MG Tablet (APOTEX INC, DIN 02538709): 1 other product with no open report; est. end 2026-12-11 - CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE 2MG Solution (OMEGA LABORATORIES LIMITED, DIN 02408813): 1 other product with no open report (check presentation); est. end 2027-01-15 - HEPARIN SODIUM INJECTION USP 10000UNIT Solution (PFIZER CANADA ULC, DIN 02382326): 2 other products with no open report (check presentation); no end date given - TEVA-LENOLTEC NO. 1 8MG / 300MG / 15MG Tablet (TEVA CANADA LIMITED, DIN 00653233): 2 other products with no open report; est. end 2026-12-10 - TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT 5% / 1% Gel (TARO PHARMACEUTICALS INC, DIN 02464519): 2 other products with no open report; est. end 2027-01-22 New, with another maker that has no open report (69) - PARIET, ENTERIC-COATED TABLET 20MG 20MG Tablet (enteric-coated) (JANSSEN INC, DIN 02243797): 1 other product with no open report; est. end 2027-01-15 - APO-AMLODIPINE-ATORVASTATIN 10MG / 80MG Tablet (APOTEX INC, DIN 02411342): 1 other product with no open report; est. end 2026-12-04 - SANDOZ ENTACAPONE 200MG Tablet (SANDOZ CANADA INCORPORATED, DIN 02380005): 1 other product with no open report; est. end 2026-11-27 - APO-CANAGLIFLOZIN 300MG Tablet (APOTEX INC, DIN 02564564): 2 other products with no open report; est. end 2027-01-08 - TEVA-NABILONE 0.5MG Capsule (TEVA CANADA LIMITED, DIN 02384884): 1 other product with no open report; est. end 2026-12-10 - DILTIAZEM CD 300MG Capsule (controlled-delivery) (SANIS HEALTH INC, DIN 02400464): 2 other products with no open report; est. end 2027-03-19 - LISINOPRIL/HCTZ (TYPE Z) 12.5MG / 10MG Tablet (SANIS HEALTH INC, DIN 02362945): 2 other products with no open report; no end date given - APO-OXYCODONE/ACET 325MG / 5MG Tablet (APOTEX INC, DIN 02324628): 1 other product with no open report; est. end 2026-12-18 - CESAMET 0.5MG Capsule (BAUSCH HEALTH, CANADA INC., DIN 02256193): 1 other product with no open report; est. end 2027-01-15 - PANTOPRAZOLE 20MG Tablet (delayed-release) (SANIS HEALTH INC, DIN 02536137): 3 other products with no open report; est. end 2027-01-15 - PANTOPRAZOLE 40MG Tablet (delayed-release) (SANIS HEALTH INC, DIN 02370808): 18 other products with no open report; est. end 2027-01-15 - NAT-BENDAMUSTINE 25MG Powder for solution (NATCO PHARMA (CANADA) INC, DIN 02496887): 3 other products with no open report (check presentation); est. end 2027-12-31 - NAT-BENDAMUSTINE 100MG Powder for solution (NATCO PHARMA (CANADA) INC, DIN 02496895): 3 other products with no open report (check presentation); est. end 2027-12-31 - PMS-AMIODARONE 200MG Tablet (PHARMASCIENCE INC, DIN 02242472): 8 other products with no open report; est. end 2026-12-03 - COVERSYL 4MG Tablet (SERVIER CANADA INC, DIN 02123282): 17 other products with no open report; est. end 2026-12-02 - ARICEPT 10MG Tablet (PFIZER CANADA ULC, DIN 02232044): 16 other products with no open report; no end date given - APO-PANTOPRAZOLE 40MG Tablet (delayed-release) (APOTEX INC, DIN 02292920): 18 other products with no open report; est. end 2026-12-11 - APO-DOXY-TABS 100MG Tablet (APOTEX INC, DIN 00874256): 8 other products with no open report; est. end 2027-01-08 - SANDOZ CANDESARTAN 4MG Tablet (SANDOZ CANADA INCORPORATED, DIN 02326957): 8 other products with no open report; est. end 2026-11-27 - LUVOX 50MG Tablet (BGP PHARMA ULC, DIN 01919342): 2 other products with no open report; est. end 2026-11-27 - APO-AZITHROMYCIN Z 250MG Tablet (APOTEX INC, DIN 02415542): 13 other products with no open report; est. end 2026-12-11 - APO-DORZO-TIMOP 20MG / 5MG Solution solution (APOTEX INC, DIN 02299615): 7 other products with no open report; est. end 2026-12-04 - APO-DESVENLAFAXINE 100MG Tablet (extended-release) (APOTEX INC, DIN 02466996): 8 other products with no open report; est. end 2027-01-08 - APO-ATOMOXETINE 60MG Capsule (APOTEX INC, DIN 02318067): 7 other products with no open report; est. end 2027-01-08 - APO-ESCITALOPRAM 10MG Tablet (APOTEX INC, DIN 02295016): 19 other products with no open report; est. end 2027-01-15 ... and 44 more Tier 3 reports new or changed this week (2 of 27 open) - ERELZI 25MG Solution (SANDOZ CANADA INCORPORATED, DIN 02462877) [Tier 3]: no other marketed product; est. end 2027-02-12 - DACARBAZINE FOR INJECTION BP 600MG Powder for solution (PFIZER CANADA ULC, DIN 02241445) [Tier 3]: no other marketed product; est. end 2028-12-31 Marked resolved (45) - PMS-FLUCONAZOLE 50MG (PHARMASCIENCE INC, DIN 02245643) - APO-ESOMEPRAZOLE 20MG (APOTEX INC, DIN 02339099) - APO-ATOMOXETINE 10MG (APOTEX INC, DIN 02318024) - APO-ATOMOXETINE 25MG (APOTEX INC, DIN 02318040) - APO-OMEPRAZOLE 20MG (APOTEX INC, DIN 02245058) - PROCHLORAZINE 10MG (AA PHARMA INC, DIN 00886432) - METHYLDOPA 125MG (AA PHARMA INC, DIN 00360252) - METHOPRAZINE 5MG (AA PHARMA INC, DIN 02238404) - CREON MINIMICROSPHERES 35 35000UNIT / 2240UNIT / 35700UNIT (BGP PHARMA ULC, DIN 02494639) - SYNTHROID 50MCG (BGP PHARMA ULC, DIN 02172070) - MYLAN-MIRTAZAPINE 15MG (MYLAN PHARMACEUTICALS ULC, DIN 02256096) - SANDOZ RISPERIDONE 2MG (SANDOZ CANADA INCORPORATED, DIN 02279819) - TEVA-CHLOROQUINE 250MG (TEVA CANADA LIMITED, DIN 00021261) - DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP 10MG (SANDOZ CANADA INCORPORATED, DIN 00874582) - PREGABALIN 300MG (SANIS HEALTH INC, DIN 02405598) - AURO-CEPHALEXIN 125MG (AURO PHARMA INC, DIN 02497743) - TARO-LENALIDOMIDE 2.5MG (TARO PHARMACEUTICALS INC, DIN 02507862) - TARO-LENALIDOMIDE 20MG (TARO PHARMACEUTICALS INC, DIN 02507900) - BESIVANCE 0.6% (BAUSCH & LOMB INC, DIN 02336847) - ACUVAIL 0.45% (ABBVIE CORPORATION, DIN 02369362) - FML 0.1% (ABBVIE CORPORATION, DIN 00247855) - TARO-RAMIPRIL HCTZ 25MG / 10MG (SUN PHARMA CANADA INC, DIN 02449471) - APO-DUTASTERIDE 0.5MG (APOTEX INC, DIN 02404206) - PMS-METHYLPHENIDATE CR 15MG (PHARMASCIENCE INC, DIN 02536951) - APO-DESVENLAFAXINE 50MG (APOTEX INC, DIN 02466988) ... and 20 more Data note: 49.7% of open reports have not been updated in over a year. Source: manufacturer reports to Health Canada (healthproductshortages.ca) and Health Canada's Drug Product Database. "No open report" is not a stock check. Same-ingredient matches are not statements of interchangeability. Not medical advice. https://github.com/utsavamehta-cloud/canada-drug-shortage-monitor